Indian drug makers wary as US FDA sharpens focus on quality controlPost published:May 16, 2017Post category:Industry NewsThe US FDA has increased the frequency of its inspections but also intensified scrutiny on drug manufacturing facilities in India Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostFacebook’s Sheryl Sandberg urges family-friendly policies on Mother’s Day Next PostLithium supply may be key to government’s electric vehicles push You Might Also Like Amazon is said to test delivery service to rival FedEx, UPS October 6, 2017 Kvaser announces Kvaser Air Bridge Light HS wireless CAN bridge December 14, 2018 Festo to introduce BionicSoftHand and BionicSoftArm at Hanover Fair 2019 March 25, 2019